Literature DB >> 30388563

Recent advances in biosensors for diagnosis and detection of sepsis: A comprehensive review.

Sanni Kumar1, Suryasnata Tripathy2, Anupam Jyoti3, Shiv Govind Singh4.   

Abstract

Sepsis is one of the leading causes of mortality among critically ill patients globally. According to WHO report 2018, it is estimated to affect beyond 30 million people worldwide every year. It causes loss of human lives, which arise from infection and inflammation and long term stay in intensive care unit (ICU) in hospitals. Despite the availability of satisfactory prognostic markers contributing to the diagnosis of sepsis, millions of people die even after admission to the hospitals. Correct and early diagnosis of sepsis leads to rapid administration of appropriate antibiotics can thus potentially avert the attainment to critical stages of sepsis, thereby saving human lives. Conventional diagnostic practices are costly, time consuming and they lack adequate sensitivity and selectivity, provoking an urgent need for developing alternate sepsis diagnosis systems. Nevertheless, biosensors have the much-treasured scope for reasonable sepsis diagnosis. Advancement in nano-biotechnology has provided new paradigm for biosensor platforms with upgraded features. Here, we provide an overview of the recent advances in biosensors with a brief introduction to sepsis, followed by the conventional methods of diagnosis and bio-sensing. To conclude, a proactive role and an outlook on technologically advanced biosensor platforms are discoursed with possible biomedical applications.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Biomarkers; Biosensors; Infection; Inflammation; Nanotechnology; Sepsis

Mesh:

Substances:

Year:  2018        PMID: 30388563     DOI: 10.1016/j.bios.2018.10.034

Source DB:  PubMed          Journal:  Biosens Bioelectron        ISSN: 0956-5663            Impact factor:   10.618


  26 in total

Review 1.  Lubricin as a Therapeutic and Potential Biomarker in Sepsis.

Authors:  Holly Richendrfer; Gregory D Jay
Journal:  Crit Care Clin       Date:  2019-10-21       Impact factor: 3.598

Review 2.  Label-Free Physical Techniques and Methodologies for Proteins Detection in Microfluidic Biosensor Structures.

Authors:  Georgii Konoplev; Darina Agafonova; Liubov Bakhchova; Nikolay Mukhin; Marharyta Kurachkina; Marc-Peter Schmidt; Nikolay Verlov; Alexander Sidorov; Aleksandr Oseev; Oksana Stepanova; Andrey Kozyrev; Alexander Dmitriev; Soeren Hirsch
Journal:  Biomedicines       Date:  2022-01-18

3.  Suggestion for a new bacteriophage genus for the Klebsiella pneumoniae phage vB_KpnS-Carvaje.

Authors:  Jéssica C Sousa; Sanna Sillankorva; Alberta Faustino; Carla M Carvalho
Journal:  Curr Genet       Date:  2022-06-06       Impact factor: 2.695

4.  LINC00261 relieves the progression of sepsis-induced acute kidney injury by inhibiting NF-κB activation through targeting the miR-654-5p/SOCS3 axis.

Authors:  Xinying Li; Jinying Li; Ping Lu; Mingzhe Li
Journal:  J Bioenerg Biomembr       Date:  2021-01-22       Impact factor: 2.945

Review 5.  Antimicrobial Peptides as Probes in Biosensors Detecting Whole Bacteria: A Review.

Authors:  Éric Pardoux; Didier Boturyn; Yoann Roupioz
Journal:  Molecules       Date:  2020-04-24       Impact factor: 4.411

Review 6.  Epigenetics in Sepsis: Understanding Its Role in Endothelial Dysfunction, Immunosuppression, and Potential Therapeutics.

Authors:  Deborah Cross; Ruth Drury; Jennifer Hill; Andrew J Pollard
Journal:  Front Immunol       Date:  2019-06-18       Impact factor: 7.561

Review 7.  Aptamer-based biosensors for the diagnosis of sepsis.

Authors:  Lubin Liu; Zeyu Han; Fei An; Xuening Gong; Chenguang Zhao; Weiping Zheng; Li Mei; Qihui Zhou
Journal:  J Nanobiotechnology       Date:  2021-07-19       Impact factor: 10.435

8.  Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.

Authors:  Qiongyi Hu; Wen Gong; Jieyu Gu; Guannan Geng; Ting Li; Rui Tian; Zhitao Yang; Haocheng Zhang; Lingyun Shao; Tingting Liu; Liyan Wan; Jinchao Jia; Chengde Yang; Yi Shi; Hui Shi
Journal:  Front Immunol       Date:  2019-01-11       Impact factor: 7.561

9.  Dexmedetomidine Protects Against Lipopolysaccharide-Induced Acute Kidney Injury by Enhancing Autophagy Through Inhibition of the PI3K/AKT/mTOR Pathway.

Authors:  Yuan Zhao; Xiujing Feng; Bei Li; Jichen Sha; Chaoran Wang; Tianyuan Yang; Hailin Cui; Honggang Fan
Journal:  Front Pharmacol       Date:  2020-02-25       Impact factor: 5.810

Review 10.  The Pathogenesis of Sepsis and Potential Therapeutic Targets.

Authors:  Min Huang; Shaoli Cai; Jingqian Su
Journal:  Int J Mol Sci       Date:  2019-10-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.